Reserve Bank Allows ECB Lenders to Extend Loans in Rupees
Mumbai: Relaxing norms for external commercial borrowings (ECBs), the Reserve Bank of India (RBI) on Wednesday said ECB lenders can now extend loans in rupees to domestic businesses.
"With a view to providing greater flexibility for structuring of external commercial borrowings (ECB) arrangements, it has been decided that recognised non-resident ECB lenders may extend loans in Indian rupees," the RBI said in a notification.
The RBI further said that for lending in rupees, the lender would have to follow certain conditions including currency swaps with authorised banks.
"The ECB contract should comply with all other conditions applicable to the automatic and approval routes as the case may be," it added.
Also, the all-in-cost of such ECBs should be commensurate with prevailing market conditions, it added.
The apex bank further said that for executing swaps for ECBs denominated in rupees, the lender could also set up a representative office in India.
Funds raised from overseas in domestic currency will help Indian companies deal with risks associated with currency fluctuation.
Meanwhile, in another notification on transfer of assets and liabilities of Urban Cooperative Banks to commercial banks, the RBI said "the acquiring bank should not incur any loss arising out of the said merger/ transfer of assets and liabilities".
Also, big depositors holding deposits in excess of Rs 1 lakh each will be required to sacrifice in proportion to the deposit erosion of the target bank.
The 2010 circular in this regard has been amended with a view to ensuring that the process of consolidation is undertaken in a transparent manner without affecting the financial health of the acquiring entities and the banking system as a whole.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.